2,4-Dichloro-N-(4-(methylthio)-1-(2-(2-morpholinothiazole-4-carbonyl)hydrazinyl)-1-oxobutan-2-yl)benzamide

Catalog No. :
ACIGDV629
CAS No. :
1093780-94-9
Molecular Formula :
C20H23Cl2N5O4S2
Molecular Weight :
532.47

IUPAC Name:2,4-dichloro-N-(4-(methylthio)-1-(2-(2-morpholinothiazole-4-carbonyl)hydrazineyl)-1-oxobutan-2-yl)benzamide

2,4-Dichloro-N-(4-(methylthio)-1-(2-(2-morpholinothiazole-4-carbonyl)hydrazinyl)-1-oxobutan-2-yl)benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,4-Dichloro-N-(4-(methylthio)-1-(2-(2-morpholinothiazole-4-carbonyl)hydrazinyl)-1-oxobutan-2-yl)benzamide
IUPAC Name2,4-dichloro-N-(4-(methylthio)-1-(2-(2-morpholinothiazole-4-carbonyl)hydrazineyl)-1-oxobutan-2-yl)benzamide
Molecular FormulaC20H23Cl2N5O4S2
Molecular Weight532.47
SMILESO=C(NC(CCSC)C(NNC(C1=CSC(N2CCOCC2)=N1)=O)=O)C3=CC=C(Cl)C=C3Cl
InChI KeyWQFSFIJYGDPANA-UHFFFAOYSA-N
Synonym4-Thiazolecarboxylic acid, 2-(4-morpholinyl)-, 2-[2-[(2,4-dichlorobenzoyl)amino]-4-(methylthio)-1-oxobutyl]hydrazide;2,4-Dichloro-N-(4-(methylthio)-1-(2-(2-morpholinothiazole-4-carbonyl)hydrazinyl)-1-oxobutan-2-yl)benzamide
CAS No.1093780-94-9

Synthetic Route by SureRoute

1. ACIGDV629 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIGDV629 route product structure diagram
    ACIGDV6291093780-94-9
Inquiry

2. ACIGDV629 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLSUZ192 route compound structure diagram
    ACLSUZ192906353-04-6 In Stock
  4. Then
  5. ACIGDV629 route product structure diagram
    ACIGDV6291093780-94-9
Inquiry

Comments (0)